Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Invested Capital (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 13 years of Return on Invested Capital data on record, last reported at 0.13% in Q2 2025.

  • For Q2 2025, Return on Invested Capital fell 6.0% year-over-year to 0.13%; the TTM value through May 2025 reached 0.13%, down 6.0%, while the annual FY2025 figure was 0.13%, 5.0% down from the prior year.
  • Return on Invested Capital reached 0.13% in Q2 2025 per LFCR's latest filing, up from 0.16% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q3 2022 and bottomed at 7.53% in Q1 2022.
  • Average Return on Invested Capital over 5 years is 0.58%, with a median of 0.1% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: plummeted -750bps in 2022, then surged 749bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then tumbled by -1480bps to 0.05% in 2022, then tumbled by -437bps to 0.28% in 2023, then skyrocketed by 61bps to 0.11% in 2024, then decreased by -23bps to 0.13% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.13% in Q2 2025, 0.16% in Q1 2025, and 0.11% in Q4 2024.